US Stock MarketDetailed Quotes

Virpax Pharmaceuticals (VRPX)

Watchlist
  • 0.0111
  • 0.00000.00%
15min DelayClose Apr 21 14:19 ET
13.79KMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Virpax Pharmaceuticals (VRPX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-28.69%12.08M
-42.79%3.39M
-68.53%1.92M
6.76%3.46M
100.02%3.3M
-22.46%16.94M
91.29%5.93M
-20.74%6.12M
-45.13%3.24M
-67.78%1.65M
Selling and administrative expenses
-47.04%6.26M
-52.71%2.29M
-83.09%780.96K
-22.91%1.5M
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
-General and administrative expense
-47.04%6.26M
-52.71%2.29M
-83.09%780.96K
-22.91%1.5M
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
Research and development costs
13.71%5.82M
1.00%1.11M
-23.55%1.14M
51.54%1.96M
30.56%1.61M
-52.45%5.12M
-19.30%1.1M
-46.68%1.5M
-60.39%1.29M
-63.02%1.24M
Operating profit
28.69%-12.08M
42.79%-3.39M
68.53%-1.92M
-6.76%-3.46M
-100.02%-3.3M
22.46%-16.94M
-91.29%-5.93M
20.74%-6.12M
45.13%-3.24M
67.78%-1.65M
Net non-operating interest income expense
-103.75K
0
-92.75K
-11K
0
0
Non-operating interest expense
--103.75K
--0
--92.75K
--11K
----
----
----
--0
--0
----
Other net income (expense)
-93.35%116.46K
-99.66%4.65K
-91.18%10.65K
-84.91%19.13K
-37.15%82.03K
800.29%1.75M
1,093.69%1.37M
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
Special income (charges)
----
----
----
----
----
--1.25M
----
----
----
----
-Less:Other special charges
----
----
----
----
----
---1.25M
----
----
----
----
Other non- operating income (expenses)
-76.72%116.46K
-96.20%4.65K
-91.18%10.65K
-84.91%19.13K
-37.15%82.03K
157.33%500.28K
6.45%122.39K
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
Income before tax
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Income tax
0
0
Net income
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Net income continuous Operations
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Minority interest income
Net income attributable to the parent company
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.56%-12.07M
25.68%-3.39M
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
Basic earnings per share
78.10%-71
94.16%-5.6928
91.60%-10.75
34.21%-43.75
-111.54%-68.75
29.85%-324.25
-50.58%-97.5
21.23%-128
46.80%-66.5
70.45%-32.5
Diluted earnings per share
78.10%-71
94.16%-5.6928
91.60%-10.75
34.21%-43.75
-111.54%-68.75
29.85%-324.25
-50.58%-97.5
21.23%-128
46.80%-66.5
70.45%-32.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -28.69%12.08M-42.79%3.39M-68.53%1.92M6.76%3.46M100.02%3.3M-22.46%16.94M91.29%5.93M-20.74%6.12M-45.13%3.24M-67.78%1.65M
Selling and administrative expenses -47.04%6.26M-52.71%2.29M-83.09%780.96K-22.91%1.5M306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K
-General and administrative expense -47.04%6.26M-52.71%2.29M-83.09%780.96K-22.91%1.5M306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K
Research and development costs 13.71%5.82M1.00%1.11M-23.55%1.14M51.54%1.96M30.56%1.61M-52.45%5.12M-19.30%1.1M-46.68%1.5M-60.39%1.29M-63.02%1.24M
Operating profit 28.69%-12.08M42.79%-3.39M68.53%-1.92M-6.76%-3.46M-100.02%-3.3M22.46%-16.94M-91.29%-5.93M20.74%-6.12M45.13%-3.24M67.78%-1.65M
Net non-operating interest income expense -103.75K0-92.75K-11K00
Non-operating interest expense --103.75K--0--92.75K--11K--------------0--0----
Other net income (expense) -93.35%116.46K-99.66%4.65K-91.18%10.65K-84.91%19.13K-37.15%82.03K800.29%1.75M1,093.69%1.37M64.69%120.64K554.07%126.72K1,090.15%130.53K
Special income (charges) ----------------------1.25M----------------
-Less:Other special charges -----------------------1.25M----------------
Other non- operating income (expenses) -76.72%116.46K-96.20%4.65K-91.18%10.65K-84.91%19.13K-37.15%82.03K157.33%500.28K6.45%122.39K64.69%120.64K554.07%126.72K1,090.15%130.53K
Income before tax 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Income tax 00
Net income 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Net income continuous Operations 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Minority interest income
Net income attributable to the parent company 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.56%-12.07M25.68%-3.39M66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M
Basic earnings per share 78.10%-7194.16%-5.692891.60%-10.7534.21%-43.75-111.54%-68.7529.85%-324.25-50.58%-97.521.23%-12846.80%-66.570.45%-32.5
Diluted earnings per share 78.10%-7194.16%-5.692891.60%-10.7534.21%-43.75-111.54%-68.7529.85%-324.25-50.58%-97.521.23%-12846.80%-66.570.45%-32.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.58%
Sample Name
Sample Code
 +12.97%
Sample Name
Sample Code
 +8.07%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.28%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+2.92%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.36%
Sample Name
Sample Code
 +9.99%
4
Atour Lifestyle Holdings
ATAT
+9.19%
5
Chagee Holdings
CHA
+6.02%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 22 Beijing time, reports indicated that Trump agreed to extend the ceasefire between the US and Iran by 3-5 days rather than indefi Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -